title: Letter in response to TB during TNF-α inhibitor therapy, despite screening.
authors.forename: K
authors.initials: K
authors.lastname: Manalan
authors.forename: A
authors.initials: A
authors.lastname: Singanayagam
authors.forename: M
authors.initials: M
authors.lastname: Wickremasinghe
authors.forename: O M
authors.initials: OM
authors.lastname: Kon
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D055985:Latent Tuberculosis / Q000209:etiology*; D008297:Male; D014397:Tuberculosis, Pulmonary / Q000209:etiology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha
keywords: Tuberculosis